Coronary atherosclerosis and cerebrovascular damage in a patient with systemi9c lupus erythematosus with antiphospholipid syndrome

by N V Seredavkina, T M Reshetnyak, D V Burenchev, L V Kondratyeva, E L Nasonov
Published 2008-06-01

C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology

by N V Seredavkina, T M Reshetnyak, E N Alexandrova, A A Novikov, E S Mach, T V Popkova
Published 2009-08-01

Liver Disease and Hemostasis (Review) Part 2. Cholestatic Liver Disease and Hemostasis

by Vasiliy I. Reshetnyak, Igor V. Maev, Tatiana M. Reshetnyak, Sergei V. Zhuravel, Vladimir M. Pisarev
Published 2019-12-01

Current approaches to treatment of uveitis in immune-mediated inflammatory rheumatic disease

by T. A. Lisitsyna, Z. S. Alekberova, G. A. Davydova, T. M. Reshetnyak, L. A. Katargina, E. L. Nasonov
Published 2020-09-01

Varfarin in the complex treatment of antiphospholipid syndrome: preliminary results

by T M Reshetnyak, I E Shirokova, I B Shtivelband, T A Lisicina, E A Aleksandrova, E N Aleksandrova
Published 2003-06-01

C-reactive protein prolongs blood coagulation time in phospholipids-dependent coagulation tests

by L D Kozmin, A I Martinov, T A Lisitsina, T M Reshetnyak, V. I. Lauga, O P Bliznukov
Published 2003-06-01

VALIDATION OF A RUSSIAN-LANGUAGE VERSION OF THE VEINES-QOL/SYM QUESTIONNAIRE IN PATIENTS WITH RHEUMATIC DISEASES AND LOWER EXTREMITY CHRONIC VENOUS DISEASES

by M. A. Satybaldyeva, N. V. Seredavkina, S. I. Glukhova, I. N. Gorskikh, T. M. Reshetnyak, E. L. Nasonov
Published 2017-10-01

Risk factors for venous thromboembolic events in patients with rheumatoid arthritis

by M. A. Satybaldyeva, T. M. Reshetnyak, N. V. Seredavkina, S. I. Glukhova, D. E. Karateev, E. L. Nasonov
Published 2016-10-01

Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range

by N V Seredavkina, T M Reshetnyak, M A Satybaldyeva, L N Kashnikova, T A Temnikova, E L Nasonov
Published 2019-05-01

Blood nitrates content in patients with systemic lupus erythematosus and antiphospholipid syndrome

by D V Reshetnyak, T V Kuznetsova, A G Kobylyansky, N G Klyukvina, T M Reshetnyak, E L Nasonov
Published 2004-05-01

Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity

by E. L. Nasonov, T. V. Beketova, T. M. Reshetnyak, A. M. Lila, L. P. Ananieva, T. A. Lisitsyna, S. K. Soloviev
Published 2020-09-01

Safety and efficacy of 23-valent polysaccharide pneumococcal vaccine in patients with systemic lupus erythematosus

by G. M. Tarasova, B. S. Belov, M. V. Cherkasova, E. A. Aseeva, T. M. Reshetnyak, T. V. Popkova, N. M. Kosheleva
Published 2021-06-01

RESULTS OF AN OBSERVATIONAL PROSPECTIVE STUDY OF THE EFFICACY AND SAFETY OF BELIMUMAB (BENLYSTA®) IN SYSTEMIC LUPUS ERYTHEMATOSUS IN REAL CLINICAL PRACTICE

by E. A. Aseeva, S. K. Soloviev, A. A. Mesnyankina, T. M. Reshetnyak, N. E. Lopatina, S. I. Glukhova, E. L. Nasonov
Published 2016-03-01

The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome

by Tatiana M. Reshetnyak, Irina A. Doroshkevich, Natalia V. Seredavkina, Evgeny L. Nasonov, Igor V. Maev, Vasiliy I. Reshetnyak
Published 2019-01-01

The first Russian experience with the endothelin 1 receptor inhibitor traclir used in patients with pulmonary hypertension associated with systemic connective tissue diseases

by Aleksandr Vitalyevich Volkov, T V Martynyuk, N N Yudkina, N M Danilov, T M Reshetnyak, I E Chazova, E L Nasonov
Published 2011-12-01

MARKERS OF INFLAMMATION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND CARDIOVASCULAR PATHOLOGY

by Nataliya Valer'evna Seredavkina, T M Reshetnyak, E N Aleksandrova, A A Novikov, E S Mach, D S Novikova, M A Diatroptova, E L Nasonov, Nataliya Valeryevna Seredavkina, T M Reshetnyak, E N Aleksandrova, A A Novikov, E S Mach, D S Novikova, M A Diatroptova, E L Nasonov
Published 2010-10-01

Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome

by A A Novikov, E N Alexandrova, T V Popkova, T M Reshetnyak, N G Klyukvina, D S Novikova, LB Slitivelband, A A Baranov
Published 2004-08-01

The System of Blood Coagulation in Normal and in Liver Transplantation (Review)

by V. I. Reshetnyak, S. V. Zhuravel, N. K. Kuznetsova, V. М. Pisarev, E. V. Klychnikova, V. Е. Syutkin, Т. M. Reshetnyak
Published 2018-10-01

INVESTIGATION OF IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

by G. M. Tarasova, B. S. Belov, D. V. Bukhanova, M. V. Cherkasova, S. K. Solovyev, E. A. Aseeva, T. M. Reshetnyak, T. V. Popkova
Published 2018-09-01

Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up

by T M Reshetnyak, Z S Alekberova, G P Kotelnikova, E N Alexandrova, E S Mack, S G Radenska-Lopovok, L A Kalashnikova, V A Nasonova
Published 2003-05-01